Drug Firms Fail to Conduct Post-Marketing Studies – (05-20-00)



Drug Firms Fail to Conduct Post-Marketing Studies

Sometimes it seems that the government has less and less control over the pharmaceutical companies. This is a perfect example of the drug companies ignoring mandates from the FDA. Apr 17 (Reuters) – Most of the studies that federal health officials require drug companies to perform on new medicines after they hit the market are never done, a US consumer group charged on Thursday. Often when the Food and Drug Administration (FDA) approves a drug, it orders the manufacturer to conduct further studies of side effects or how well it works for certain patients. But only 13% of the 88 follow-up studies required for drugs launched in the early 1990s were completed, according to a report by consumer group Public Citizen. No studies were finished for 107 drugs that went on the market between January 1995 and last December, the group said.

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Drug Research
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”